XRAY

In the past six months, Dentsply Sirona's stock has been impacted by several key events. The company reported a GAAP net loss per share of ($2.14) in Q3 2025. In Q4 2025, net sales increased by 6.2%, but a net loss was reported due to goodwill and intangible impairments; a restructuring initiative was announced, and a new capital allocation strategy was initiated. In Q1 2026, net sales were flat year-on-year but beat analyst expectations, and the company reiterated its full-year 2026 outlook for net sales and adjusted EPS. The stock price as of April 30, 2026, was $11.75 per share, representing a decline of 16.55% from May 2, 2025. As of May 8, 2026, the closing price was $10.98.